turning plants into mini-biofactories
RECOMBINANT DNA TECHNOLOGY
What the public needs to understand is that recombinant DNA technology allows scientists to bypass biological boundaries altogether.
Uzzo Calderaro, Chief Business Development Officer
TURNING PLANTS INTO MINI-BIOFACTORIES
Plants are highly efficient at producing proteins of varying complexity, serving as bioreactors - or mini factories - for protein-based therapeutics. Perpetuum's plant-based production platform demonstrates better agility, accuracy, and speed compared with other manufacturing technologies by eliminating the risk of pathogens and contamination during production, and significantly shortening production timelines.
Our platform scaleability is quite simple; one plant or 10,000 plants require the same growth conditions whereas the capacity is adjustable to market needs.